Clinical Trials
10 trialsNCT00623077 2017-12-05
MT2004-30: Tomotherapy for Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated
NCT00066365 2015-03-30
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
Children's Oncology Group
Phase 2 Completed
NCT00002995 2014-02-14
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Children's Oncology Group
Phase 3 Completed
NCT00003955 2014-02-14
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
Children's Oncology Group
Phase 2 Completed
NCT00003958 2013-06-17
Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
Children's Oncology Group
Phase 3 Completed
NCT00033644 2013-04-11
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
GOG Foundation
Phase 2 Terminated
NCT00003408 2013-03-26
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00027911 2013-02-15
Vaccine Therapy and Sargramostim in Treating Patients With Soft Tissue Sarcoma
Columbia University
Phase 1 Terminated
NCT00652860 2011-05-16
Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT00069940 2010-12-28
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Dana-Farber Cancer Institute
Phase 1 Completed